Analysts Are Updating Their 10x Genomics, Inc. (NASDAQ:TXG) Estimates After Its First-Quarter Results

BioPharma DiveLilly data point to ‘maintenance’ strategies for GLP-1 weight loss

FierceBiotechHumacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

FierceBiotechWith $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’

Endpoints NewsPost-Hoc: Why FDA Commissioner Marty Makary was ousted

FierceBiotechFosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset

BioPharma DiveAssertio accepts new buyout bid; AI biotech Isomorphic banks $2B

LabCorpLabcorp stock (US50540R4092): Enhances Partnership with Epic for Lab Services - AD HOC NEWS

Eli LillyEli Lilly shows sustained weight loss in new pill study - medwatch.com

CatalentElpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing - Contract Pharma

Endpoints NewsBehind Galapagos’ transformation into Lakefront Biotherapeutics

FierceBiotechValneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines

PharmaVoiceIndia’s pharma industry is going global. But can it catch up to China?